RARA CRAFT DATABASE for FDA Medical Devices
510(k)K201377

FDA DEVICE FACTS

SABERX RADIANZ Percutaneous Transluminal Angioplasty Dilatation Catheter

Cordis Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 9, 2020PRODUCT CODELIT

Indications for use

The SABERX RADIANZ™ PTA Catheter is intended to dilate stenoses in iliac, femoral, ilio-femoral, popliteal, infra popliteal and renal arteries. The device is also indicated for post-dilation of balloon-expandable and self-expanding stents in the peripheral vasculature The Indications for Use statement for SABERX RADIANZ™ is similar to the predicate device. The subject and predicate devices have the same fundamental intended use, which is to dilate stenoses in iliac, femoral, ilio-femoral, popliteal, infra popliteal and renal arteries and for stent post-dilation. Minor differences in the Indications for Use statements do not alter the intended use, or raise different questions of safety and effectiveness relative to the predicate.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026